聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 42 分钟 52 秒 前

ETView Reports on Clinical Evaluation of VivaSight(TM)

周二, 02/24/2015 - 13:28
University Hospital Zurich, (Zurich, Switzerland) Evaluated VivaSight™ in 40 Patients Undergoing One Lung Ventilation. Results Demonstrate Elimination of Flexible Fiberoptic Bronchoscopy, and Reduction in Procedure Time TEL AVIV, Israel--(Healthcare Sal...
Devices
ETView Medical, VivaSight, endotracheal tubes, bronchoscopy

Nakashima and Teijin to Establish Joint Venture for Global Expansion of Japanese-made Medical Device Business

周一, 02/23/2015 - 14:07
Tokyo, Japan, February 23, 2015 -(Healthcare Sales & Marketing Network)- Nakashima Holdings Co., Ltd. and Teijin Limited announced today that Teijin will acquire, through a third-party allotment, new shares of Nakashima Medical Co., Ltd., Nakashima Holding...
Devices, Orthopaedic, Mergers & Acquisitions
Teijin, Nakashima

Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer

周一, 02/23/2015 - 13:45
Analysis of 285 Patient Subgroup Shows an Impressive Statistically Significant 59% Improvement in Overall Survival Results at Two Years Post Treatment Continue to Support Protocol for Ongoing Phase III OPTIMA Trial LAWRENCEVILLE, N.J., Feb. 23, 2015 ...
Biopharmaceuticals, Oncology
Celsion, ThermoDox, doxorubicin, liver cancer

Eiger BioPharmaceuticals Announces Presentation of Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib

周一, 02/23/2015 - 13:37
NIH Principal Investigator to Present Abstract and Poster at Conference on Retroviruses and Opportunistic Infections (CROI) PALO ALTO, Calif., Feb. 23, 2015 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc. announced today tha...
Biopharmaceuticals
Eiger BioPharmaceuticals, lonafarnib, hepatitis delta viral

Compugen Expands and Strengthens Business Development Team

周一, 02/23/2015 - 13:28
Felix Karim, PhD, joins Company as Vice President Corporate & Business Development TEL AVIV, Israel--(Healthcare Sales & Marketing Network)--Compugen Ltd. (NASDAQ: CGEN) today announced the appointment of Dr. Felix Karim as Vice President Corporate & Bu...
Biopharmaceuticals, Oncology, Personnel
Compugen, monoclonal

Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi(R) and Harvoni(R) in India

周一, 02/23/2015 - 13:21
PITTSBURGH and HYDERABAD, India, Feb. 23, 2015 -- (Healthcare Sales & Marketing Network) -- Mylan Inc. (MYL) today announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which...
Biopharmaceuticals, Distribution
Mylan , Mylan Pharmaceuticals Private Limited, Gilead Sciences, Sovaldi, Harvoni

REVLIMID(R) (Lenalidomide) Approved by the European Commission for the Treatment of Adult Patients with Previously Untreated Multiple Myeloma who are Not Eligible for Transplant

周五, 02/20/2015 - 13:06
Oral REVLIMID is approved for treatment until disease progression BOUDRY, Switzerland--(Healthcare Sales & Marketing Network)--Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (CELG), today announced that the European ...
Biopharmaceuticals, Oncology, Regulatory
Celgene International Sàrl, REVLIMID, lenalidomide, multiple myeloma

ZS Pharma Hires Key Medical Affairs and Commercial Executives

周四, 02/19/2015 - 21:23
As ZS-9 Nears NDA and MAA Submissions, ZS Pharma Adds Key Members to Its Medical Affairs and Commercial Leadership Team REDWOOD CITY, Calif., Feb. 19, 2015 -- (Healthcare Sales & Marketing Network) -- ZS Pharma (ZSPH), a biopharmaceutical company develo...
Biopharmaceuticals, Personnel
ZS Pharma

Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides

周四, 02/19/2015 - 21:11
NEWTOWN SQUARE, Pa.--(Healthcare Sales & Marketing Network)--Merganser Biotech Inc. announced today that the company has raised $28 million in a Series A financing round. The round was led by the Novartis Venture Fund, joined by Frazier Healthcare, Sutter ...
Biopharmaceuticals, Venture Capital
Merganser Biotech, hepcidin mimetic

Lifecode Receives CAP Accreditation, Discloses $20.5M Series A-Round Funding Led By Sequoia Capital, the Mayo Clinic and Mayo Ventures

周四, 02/19/2015 - 19:56
FOSTER CITY, Calif.--(Healthcare Sales & Marketing Network)--Lifecode Inc., a rapidly growing next-generation-sequencing (NGS) based molecular diagnostics company, announced today that it has received accreditation from the College of American Pathologists...
Diagnostics, Oncology, Venture Capital
Lifecode, molecular profiling

FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma

周四, 02/19/2015 - 11:30
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the company’s...
Biopharmaceuticals, Oncology, FDA
Genentech, Roche Group, cobimetinib, melanoma, BRAF V600

Dance Biopharm Completes $9.5 Million Private Financing

周三, 02/18/2015 - 13:25
Total Funds Raised to Date Exceed $33 Million BRISBANE, Calif., Feb. 18, 2015 -- (Healthcare Sales & Marketing Network) -- Dance Biopharm Inc. (Dance), a privately-held biotechnology company focused on the development of inhaled insulin products to tre...
Biopharmaceuticals, Venture Capital
Dance Biopharm

aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD

周三, 02/18/2015 - 13:18
SAN DIEGO, Feb. 18, 2015 -- (Healthcare Sales & Marketing Network) -- aTyr Pharma, Inc. ("aTyr"), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, announced today the ...
Biopharmaceuticals, Regulatory
aTyr Pharma, Resolaris, FSHD, orphan drug designation

Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy

周三, 02/18/2015 - 13:10
Wendy Blosser Will Join Company as VP, Sales; Robin Harper Cowie Promoted to Vice President, Reimbursement and Health Economics; Jasmine Gruia-Gray Becomes Vice President, Marketing BOULDER, Colo.--(Healthcare Sales & Marketing Network)--Biodesix, Inc. ...
Diagnostics, Personnel
Biodesix, VeriStrat

Regen BioPharma, Inc. Expands Management Team With the Addition of New CFO Todd Caven

周二, 02/17/2015 - 15:18
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Regen BioPharma Inc. (OTC PINK: RGBP) announced that it has appointed Todd Caven to serve as the company's Chief Financial Officer. Mr. Caven is the cofounder of Saguaro Capital Partners, an Arizona b...
Biopharmaceuticals, Regenerative Medicine, Personnel
Regen BioPharma

BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division

周二, 02/17/2015 - 15:14
MELVILLE, N.Y.--(Healthcare Sales & Marketing Network)--BioRestorative Therapies, Inc. ("BRT" or the "Company") (BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today ...
Regenerative Medicine, Orthopaedic, Personnel
BioRestorative Therapies, brtxDISC, stem cell

Dallen Medical Receives FDA Clearance for New Tensyn(TM) Plug

周二, 02/17/2015 - 15:10
SAN CLEMENTE, Calif.--(Healthcare Sales & Marketing Network)--Dallen Medical Inc., an innovator in bone fixation and repair, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Tensyn™ Plug, the first adjustable orthop...
Devices, Orthopaedic, FDA
Dallen Medical, Tensyn Plug

Galderma Announces Availability of Soolantra(R) (ivermectin) Cream, 1%

周二, 02/17/2015 - 15:07
Newly Approved Prescription Treatment Option Now Available for Rosacea Patients in Pharmacies Nationwide FT. WORTH, Texas--(Healthcare Sales & Marketing Network)--Galderma Laboratories, L.P. today announced that Soolantra® (ivermectin) Cream, 1% – a...
Biopharmaceuticals, Dermatology, FDA, Product Launch
Galderma, Soolantra, ivermectin, rosacea

Simplify Medical Announces CE Mark for New MRI Compatible Cervical Artificial Disc

周二, 02/17/2015 - 15:02
Simplify Disc provides spine surgeons and their patients with an MRI friendly cervical artificial disc meeting a significant unmet clinical need MOUNTAIN VIEW, Calif., Feb. 17, 2015 -- (Healthcare Sales & Marketing Network) -- Simplify Medical, Inc. is...
Devices, Orthopaedic, Radiology, Regulatory
Simplify Medical, Simplify Disc, cervical disc

Boston Scientific Announces Agreement With Johnson and Johnson To Resolve Guidant Litigation

周二, 02/17/2015 - 14:35
MARLBOROUGH, Mass., Feb. 17, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced the settlement of the breach of merger agreement lawsuit brought by Johnson & Johnson against Guidant Corporation, ste...
Devices, Litigation
Boston Scientific, Johnson & Johnson, Guidant

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong